BackAnthera Pharmaceuticals Overview

Anthera Pharmaceuticals Current Cash

Anthera Pharmaceuticals's current cash is $8.1M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$8.09M
↓ 60.85% YoYΔ $-12.57M vs prior year quarter

Peer trimmed avg / median

Loading

Anthera Pharmaceuticals Current Cash History

Loading

Anthera Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Anthera Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Anthera Pharmaceuticals (ANTH) FAQ

As of the most recent data (March 2018), ANTH shows a current cash of $8.1M. That compares with $21M in the prior-year period — down 60.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ANTH's current cash is now $8.1M (was $21M) — a 60.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Anthera Pharmaceuticals is outperforming or lagging.

Tracking ANTH's current cash over time shows whether Anthera Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $8.1M That compares with $21M in the prior-year period — down 60.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Anthera Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $8.1M) with ownership activity and broader fundamentals.

Anthera Pharmaceuticals's current cash is $8.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.